b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31043474</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>26</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>14</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1526-632X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>92</Volume>\n                    <Issue>22</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>05</Month>\n                        <Day>28</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Neurology</Title>\n                <ISOAbbreviation>Neurology</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e2538-e2549</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000007572</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">The impetus for this consensus discussion was to recommend clinical trial designs that can deliver high-quality data for effective therapies for pediatric patients, in a reasonable timeframe, with a key focus on short- and long-term safety.</AbstractText>\n                <AbstractText Label="METHODS">The International Pediatric Multiple Sclerosis Study Group convened a meeting of experts to review the advances in the understanding of pediatric-onset multiple sclerosis (MS) and the advent of clinical trials for this population.</AbstractText>\n                <AbstractText Label="RESULTS">In the last few years, convincing evidence has emerged that the biological processes involved in MS are largely shared across the age span. As such, treatments proven efficacious for the care of adults with MS have a biological rationale for use in pediatric MS given the relapsing-remitting course at onset and high relapse frequency. There are also ethical considerations on conducting clinical trials in this age group including the use of placebo owing to highly active disease. It is imperative to reconsider study design and implementation based on what information is needed. Are studies needed for efficacy or should safety be the primary goal? Further, there have been major recruitment challenges in recently completed and ongoing pediatric MS trials. Phase 3 trials for every newly approved therapy for adult MS in the pediatric MS population are simply not feasible.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">A primary goal is to ensure high-quality evidence-based treatment for children and adolescents with MS, which will improve our understanding of the safety of these agents and remove regulatory or insurance-based limitations in access to treatment.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Waubant</LastName>\n                    <ForeName>Emmanuelle</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston. emmanuelle.waubant@ucsf.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Banwell</LastName>\n                    <ForeName>Brenda</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wassmer</LastName>\n                    <ForeName>Evangeline</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sormani</LastName>\n                    <ForeName>Maria-Pia</ForeName>\n                    <Initials>MP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Amato</LastName>\n                    <ForeName>Maria-Pia</ForeName>\n                    <Initials>MP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hintzen</LastName>\n                    <ForeName>Rogier</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Krupp</LastName>\n                    <ForeName>Lauren</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rost\xc3\xa1sy</LastName>\n                    <ForeName>Kevin</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tenembaum</LastName>\n                    <ForeName>Silvia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chitnis</LastName>\n                    <ForeName>Tanuja</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>From the UCSF MS Center (E.W.), San Francisco, CA; The Children\'s Hospital of Philadelphia (B.B.), Perelman School of Medicine, University of Pennsylvania; Birmingham Children\'s Hospital (E.W.), UK; Department of Health Sciences (M.-P. S.), University of Genova and Ospedale Policlinico San Martino IRCCS; Department NEUROFARBA (M.-P.A.), University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi (M.-P.A.), Florence, Italy; Department of Neurology (R.H.), Erasmus MC, Rotterdam, the Netherlands; MS Comprehensive Care Center at NYU Langone (L.K.), New York, NY; Division of Paediatric Neurology (K.R.), Children\'s Hospital Datteln, University Witten/Herdecke, Datteln, Germany; Pediatric MS Center (S.T.), Department of Neurology, National Pediatric Hospital Dr. Garrahan, Buenos Aires, Argentina; and Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>IPMSSG</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>K23 NS101099</GrantID>\n                    <Acronym>NS</Acronym>\n                    <Agency>NINDS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016446">Consensus Development Conference</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>01</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Neurology</MedlineTA>\n            <NlmUniqueID>0401060</NlmUniqueID>\n            <ISSNLinking>0028-3878</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>AIM</CitationSubset>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="ErratumIn">\n                <RefSource>Neurology. 2019 Oct 1;93(14):647</RefSource>\n                <PMID Version="1">31570644</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>\n                <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <InvestigatorList>\n            <Investigator ValidYN="Y">\n                <LastName>Aaen</LastName>\n                <ForeName>Gregory</ForeName>\n                <Initials>G</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Ben Adou</LastName>\n                <ForeName>Elhachmia Ait</ForeName>\n                <Initials>EA</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Al-Roughani</LastName>\n                <ForeName>Raed</ForeName>\n                <Initials>R</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Alvarez</LastName>\n                <ForeName>Veronica Gonzalez</ForeName>\n                <Initials>VG</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Anagnostouli</LastName>\n                <ForeName>Maria</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Anlar</LastName>\n                <ForeName>Banu</ForeName>\n                <Initials>B</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Armangue</LastName>\n                <ForeName>Thais</ForeName>\n                <Initials>T</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Arrambide</LastName>\n                <ForeName>Georgina</ForeName>\n                <Initials>G</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Baroncini</LastName>\n                <ForeName>Damiano</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Bembeeva</LastName>\n                <ForeName>Raisa</ForeName>\n                <Initials>R</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Benson</LastName>\n                <ForeName>Leslie</ForeName>\n                <Initials>L</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Bizjak</LastName>\n                <ForeName>Neli</ForeName>\n                <Initials>N</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Blaschek</LastName>\n                <ForeName>Astrid</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Boyko</LastName>\n                <ForeName>Alexey</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Brenton</LastName>\n                <ForeName>J Nicholas</ForeName>\n                <Initials>JN</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Br\xc3\xbcck</LastName>\n                <ForeName>Wolfgang</ForeName>\n                <Initials>W</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Klein da Costa</LastName>\n                <ForeName>Bruna</ForeName>\n                <Initials>B</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Dive</LastName>\n                <ForeName>Dominique</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Elpers</LastName>\n                <ForeName>Christiane</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Filippi</LastName>\n                <ForeName>Massimo</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>de Oliveira Fragomeni</LastName>\n                <ForeName>Manuela</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Havrdova</LastName>\n                <ForeName>Eva Kubala</ForeName>\n                <Initials>EK</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Hemingway</LastName>\n                <ForeName>Cheryl</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kornek</LastName>\n                <ForeName>Barbara</ForeName>\n                <Initials>B</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Deiva</LastName>\n                <ForeName>Kumaran</ForeName>\n                <Initials>K</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lacy</LastName>\n                <ForeName>Adrian R</ForeName>\n                <Initials>AR</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Liba</LastName>\n                <ForeName>Zuzana</ForeName>\n                <Initials>Z</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lim</LastName>\n                <ForeName>Ming</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lotze</LastName>\n                <ForeName>Tim</ForeName>\n                <Initials>T</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mah</LastName>\n                <ForeName>Jean K</ForeName>\n                <Initials>JK</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Makhani</LastName>\n                <ForeName>Naila</ForeName>\n                <Initials>N</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mar</LastName>\n                <ForeName>Soe</ForeName>\n                <Initials>S</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>McKay</LastName>\n                <ForeName>Kyla A</ForeName>\n                <Initials>KA</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Menascu</LastName>\n                <ForeName>Shay</ForeName>\n                <Initials>S</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Moiola</LastName>\n                <ForeName>Lucia</ForeName>\n                <Initials>L</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mulero</LastName>\n                <ForeName>Patricia</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Ndiaye</LastName>\n                <ForeName>Moustapha</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Neuteboom</LastName>\n                <ForeName>Rinze F</ForeName>\n                <Initials>RF</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Ness</LastName>\n                <ForeName>Jayne</ForeName>\n                <Initials>J</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lobato de Oliveira</LastName>\n                <ForeName>Enedina Maria</ForeName>\n                <Initials>EM</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Otallah</LastName>\n                <ForeName>Scott</ForeName>\n                <Initials>S</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Patti</LastName>\n                <ForeName>Francesco</ForeName>\n                <Initials>F</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Albino da Paz</LastName>\n                <ForeName>Jose</ForeName>\n                <Initials>J</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Perez</LastName>\n                <ForeName>Carlos A</ForeName>\n                <Initials>CA</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Pohl</LastName>\n                <ForeName>Daniela</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Ponsonby</LastName>\n                <ForeName>Anne-Louise</ForeName>\n                <Initials>AL</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Rensel</LastName>\n                <ForeName>Mary</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Rocca</LastName>\n                <ForeName>Maria A</ForeName>\n                <Initials>MA</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Rijke</LastName>\n                <ForeName>Nick</ForeName>\n                <Initials>N</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Rodriguez</LastName>\n                <ForeName>Moses</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Rossman</LastName>\n                <ForeName>Ian</ForeName>\n                <Initials>I</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Sakuma</LastName>\n                <ForeName>Hiroshi</ForeName>\n                <Initials>H</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Schreiner</LastName>\n                <ForeName>Teri L</ForeName>\n                <Initials>TL</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Schteinschnaider</LastName>\n                <ForeName>Angeles</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Sikes</LastName>\n                <ForeName>E Morghen</ForeName>\n                <Initials>EM</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Simone</LastName>\n                <ForeName>Isabella Laura</ForeName>\n                <Initials>IL</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Sweeney</LastName>\n                <ForeName>Michael</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Tillema</LastName>\n                <ForeName>Jan Mendelt</ForeName>\n                <Initials>JM</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Troxell</LastName>\n                <ForeName>Regina M</ForeName>\n                <Initials>RM</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Verhelst</LastName>\n                <ForeName>Helene</ForeName>\n                <Initials>H</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Vilchez</LastName>\n                <ForeName>Leidi</ForeName>\n                <Initials>L</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>De Waele</LastName>\n                <ForeName>Liesbeth</ForeName>\n                <Initials>L</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Weinstock-Guttman</LastName>\n                <ForeName>Bianca</ForeName>\n                <Initials>B</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Wilbur</LastName>\n                <ForeName>Colin</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Yann</LastName>\n                <ForeName>Mikaeloff</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Yeh</LastName>\n                <ForeName>E Ann</ForeName>\n                <Initials>EA</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Zafeiriou</LastName>\n                <ForeName>Dimitrios</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n        </InvestigatorList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31043474</ArticleId>\n            <ArticleId IdType="pii">WNL.0000000000007572</ArticleId>\n            <ArticleId IdType="doi">10.1212/WNL.0000000000007572</ArticleId>\n            <ArticleId IdType="pmc">PMC6556085</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>N Engl J Med. 2007 Jun 21;356(25):2603-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17582070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mult Scler Relat Disord. 2014 Mar;3(2):186-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25878006</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pediatr. 2001 Sep;139(3):443-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11562627</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Paediatr Neurol. 2013 Jan;17(1):50-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23021975</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2006 Feb 28;66(4):472-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16505297</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Neurol. 2009 Jan;66(1):54-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19139299</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2011 Sep 20;77(12):1143-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21865580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Neurol. 2013 Jul;12(7):669-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23743084</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 2008 Mar;63(3):401-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18306242</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Paediatr Drugs. 2017 Dec;19(6):515-522</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28889403</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol Sci. 2014 Jun 15;341(1-2):79-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24792098</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Neurol. 2011 May;10(5):436-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21459044</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2017 Apr 25;88(17):1623-1629</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28356466</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pediatr. 2016 Dec;175(12):1881-1891</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27646479</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurol Sci. 2017 Apr;38(4):635-642</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28078569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mult Scler. 2012 Jan;18(1):116-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22146610</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Neurol. 2013 Apr;70(4):469-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23420110</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatrics. 2016 Jul;138(1):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27358474</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Neurol. 2015 Sep 25;15:174</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26407848</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 2009 Mar;65(3):268-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19334061</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2016 Aug 30;87(9 Suppl 2):S74-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27572865</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Child Neurol. 2013 Jul;28(7):849-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23666046</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2013 Oct 1;81(14):1215-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23966255</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2018 Sep 13;379(11):1017-1027</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30207920</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Neurol. 2018 Jun;83:19-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29681490</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Neurol. 2009 Aug;66(8):967-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19667217</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Neurol. 2018 Feb;17(2):162-173</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29275977</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Neurol. 2011 Dec;10(12):1065-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22067635</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Neurol. 2017 May;70:56-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28389054</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuropediatrics. 2001 Aug;32(4):211-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11571702</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mult Scler. 2013 Sep;19(10):1261-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23572237</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Child Neurol. 2013 Jan;28(1):102-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23155206</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2016 Aug 30;87(9 Suppl 2):S20-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27572857</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mult Scler. 2013 Apr;19(4):466-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22914849</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ther Adv Neurol Disord. 2016 Sep;9(5):389-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27582894</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2013 Mar 19;80(12):1161-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23509048</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2016 Aug 30;87(9 Suppl 2):S82-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27572867</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 2015 Apr;77(4):655-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25612167</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mult Scler. 2018 Apr;24(4):512-519</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28322606</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2018 Nov 6;91(19):e1778-e1787</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30333163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 2017 Oct;58(10):1686-1696</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28755452</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Drug Discov. 2006 Jan;5(1):27-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16485344</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'